Alzheimer’s has a huge cost, in terms of both public health and dollars spent on this disease. Researching better ways to prevent and cure this disease will save the government and the public money in the long term — and with the burgeoning elderly population, now’s the time to invest in this research.
There are already significant private sector investments in Alzheimer’s research. In the interest of saving taxpayer dollars and encouraging private innovation, the government should reduce, rather than increase, funding for Alzheimer’s research.